跳至主要内容
临床试验/DRKS00010797
DRKS00010797尚未招募未知

Improvement of the Patientenadherence and avoidance of side effects by one special speech hour for oral tumour therapy

Onkologisch-palliativmedizinisches Netzwerk Landshut0 个研究点目标入组 100 人开始时间: 2016年7月14日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • inclusion criteria
  • All patients in whom a secured hematologic or oncologic disease following entity exists and which are treated with an oral anti-proliferative therapy :
  • Colorektaleskarzinom
  • breast cancer
  • Non small cell lung cancer ( adenocarcinoma )
  • Renal Cell Carcinoma
  • Malignant melanoma
  • Mantle cell lymphoma
  • Chronic Lymphocytic Leukemia
  • follicular lymphoma
  • multiple myeloma
  • Primary myelofibrosis
  • polycythemia vera
  • Chronic myeloid leukemia
  • Written informed consent
  • Age = 18 years
  • Ability to work independently tablets
  • An adequate knowledge
  • Legal capacity
  • Estimated life expectancy = 3 months
  • ECOG performance status 0-2

排除标准

  • Lack of ability to independently tablets
  • Lack of knowledge of German or lack of ability to autonomously understand and fill out the applications described in the study questionnaires
  • Missing or limited legal capacity
  • Participation in another clinical trial with not yet approved substances
  • Any significant concomitant disease that excludes the participation of the patient in the study of the investigator 's opinion

研究者

发起方
Onkologisch-palliativmedizinisches Netzwerk Landshut

相似试验